Compass Therapeutics (CMPX) Earnings Date & Reports
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CMPX is expected to report earnings to rise 28.38% to -10 cents per share on February 27
Q4'25
Est.
$-0.10
Q3'25
Beat
by $0.06
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
The last earnings report on November 05 showed earnings per share of -7 cents, beating the estimate of -14 cents. With 1.72M shares outstanding, the current market capitalization sits at 848.40M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CMPX showed earnings on November 05, 2025. You can read more about the earnings report here.